Measles : Dutch health officials sound alarm over low vaccination rates among Moroccan families
In a recent report, RIVM stated that since 2013, vaccination coverage among children of Moroccan background has dropped significantly, from 95% to 65%. A similar trend has been observed among Turkish parents in the Netherlands, with coverage among children of Turkish background falling from 96% to 79%.
This decline has resulted in more than 100 hospitalizations, mostly involving unvaccinated children, and a total of 437 confirmed measles cases so far this year, more than double last year's figure of 204. Experts stress that a vaccination rate above 95% is necessary to prevent outbreaks.
The trend is especially pronounced in urban areas with large Moroccan and Turkish populations, such as The Hague, where some neighborhoods report coverage as low as 60%. According to Hilbert Bredemeijer, The Hague's Alderman for Education, Youth, Sports, and Services, growing distrust in government, misinformation, language barriers, and peer pressure are key factors driving vaccine hesitancy.
Moroccan families are of particular concern, as Morocco itself has seen a sharp rise in measles cases, prompting a national vaccination campaign. The country has reported 20,000 cases over the past year and a half.
In the Netherlands, many measles cases have been linked to infections imported from Morocco.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Morocco World
5 days ago
- Morocco World
500+ Healthcare Devices in Morocco Found Exposed Online with Patient Data
Rabat – More than 500 healthcare systems and devices in Morocco are exposed online, putting patient data at serious risk, according to research by cybersecurity firm Modat. The findings, shared with Morocco World News, reveal a worrying trend affecting both private and public healthcare providers in the country. Modat's research identified over 1.2 million healthcare devices and systems connected to the internet worldwide. These include MRI and CT scanners, X-ray machines, blood test systems, and hospital management software. Many of these devices store sensitive information, such as patients' names, dates of birth, and medical images, including brain scans, dental X-rays, eye exams, and MRIs used for cancer care. About 500 healthcare devices in Morocco, in both the private and public sector, were found to be exposed online. According to Modat, this creates opportunities for cybercriminals to steal sensitive patient data or misuse it for fraud. 'Many of them are exposing the patient data of Moroccan citizens leaving them vulnerable to unwanted sharing of information or even fraud,' Modat told MWN. The risks come from weak or default passwords, misconfigured network settings, and outdated software. Some systems lacked basic authentication, while others were still running on legacy software no longer supported by manufacturers. This makes them vulnerable to ransomware attacks and other cyber threats. Soufian El Yadmani, CEO of Modat, said that 'the primary risk is unnecessary network exposure.' 'These medical systems should only be connected to secure, properly configured networks when there is a legitimate clinical need for remote access,' El Yadmani added. Read also: Moroccan Authorities Warn of Unauthorised Use of Personal Data Following CNSS Leak He noted that although remote MRI operations are increasingly used to tackle staffing shortages and provide specialized expertise, many devices are still connected to the internet without sufficient cybersecurity protections. El Yadmani questioned why MRI scanners are allowed online without proper security measures, stressing the urgent need for stronger safeguards. Globally, the research showed that Europe, the United States, and the MENA region were among the most affected areas. Millions of patient records are at risk, containing sensitive Personal Health Information (PHI) and Personally Identifiable Information (PII). The highest numbers reported in the US, where over 174,000 devices were found online. South Africa follows closely with more than 172,000 exposed systems, while Australia has over 111,000. Brazil, Germany, and Ireland each reported more than 81,000 devices, with Great Britain at 77,000 and France at 75,000. Sweden accounts for 74,000, and Japan has over 48,000 exposed healthcare devices. Cybersecurity experts warn that these exposures could lead to privacy breaches, financial fraud, or even blackmail over confidential medical conditions. Modat has engaged with international partners such as Health-ISAC and Z-CERT in the Netherlands to ensure responsible disclosure and to help affected healthcare organizations address these vulnerabilities. Experts recommend that healthcare providers conduct regular security assessments, maintain updated inventories of internet-connected devices, and monitor their networks closely to prevent unauthorized access and protect patient privacy.
Morocco World
6 days ago
- Morocco World
Morocco Performs Africa's First Kidney Transplant With Different Blood Types
Rabat – The Mohammed VI Foundation for Science and Health announced on Tuesday in Casablanca that it has successfully carried out the first kidney transplant in Africa between a donor and recipient with different ABO blood types. This medical achievement was made possible through close coordination between several hospital departments, including anesthesia and intensive care, nephrology, urology, hematology, medical biology, especially immunology, the Mohammed VI Blood Transfusion Center, and a vascular surgery team. The procedure also received scientific support from Professor Lionel Rostaing , an expert in ABO-incompatible kidney transplants. Professor Abdelbar Oubaaz, Director General of a hospital under the Mohammed VI Foundation in Casablanca, said this operation is a first both in Morocco and across Africa. He explained that its success was due to the human, technical, and organizational resources available at the institution. He noted that the main challenge in such surgeries lies in preparing the patient before the transplant, which requires cooperation between experts in several medical fields, including hematology, immunology, nephrology, urology, and vascular surgery. The Moroccan medical team also received assistance from a well-known French professor to ensure the best conditions before surgery, Oubaaz added. He noted that the transplant itself was carried out entirely by Moroccan doctors. Oubaaz said the patient's condition is showing positive signs, adding that this success offers new hope to many patients who depend on dialysis. Doctor Ramdani Benyounes, head of the nephrology department at the foundation's hospitals, spoke of the strategic importance of this progress, noting that around a quarter of patients needing kidney transplants are not compatible with their donor's ABO blood type. He explained that the patient underwent a month-long preparation period, followed by intensive monitoring during the critical first weeks after the surgery. 'We are now on the sixteenth day after the transplant. The patient has normal kidney function and has completely stopped dialysis, which gives us hope that the kidney will work for many years and allow her to return to a normal life,' he concluded. Tags: AfricaHealthkidney transplant
Morocco World
12-08-2025
- Morocco World
Morocco's AMMPS Refutes Reports of 600 Chronic Disease Medication Shortages
Marrakech – The Moroccan Medicines and Health Products Agency (AMMPS) has firmly denied reports circulating in some media outlets claiming a shortage of over 600 medications for chronic diseases in the country. In an official statement, AMMPS stated that national data does not support these reported figures. The agency noted that if such extensive shortages were real, they would cause major disruptions to the healthcare system, something that has not been observed. The agency acknowledged that occasional supply disruptions can occur, a phenomenon seen internationally. These disruptions are primarily linked to supply chain tensions, difficulties accessing raw materials, or global market fluctuations – constraints beyond any single country's control. AMMPS mentioned that Morocco proactively implements necessary measures to minimize impacts and ensure treatment continuity for patients. Working closely with the Ministry of Health and Social Protection and other stakeholders, the agency's pharmaceutical market monitoring service continuously monitors and analyzes the national medication supply. This monitoring system aims to detect potential supply tensions early and deploy rapid, targeted corrective measures when necessary to preserve access to essential medications. The agency stated that this system has already proven effective in anticipating and proactively managing risk situations before they affect patients. As part of the national pharmaceutical sovereignty strategy, AMMPS is deploying a policy structured around three priorities: strengthening local production by increasing the proportion of medicines manufactured in Morocco to reduce import dependency; promoting competition and developing generics to limit monopoly situations; and securing the supply of vital medicines through proactive planning and diverse sourcing. A national uproar over drug prices The agency's dismissal of shortage reports likewise follows a fierce dispute over medicine costs in Morocco. Last month, social media erupted when a Facebook post went viral describing how Baraclude, an antiviral prescribed for hepatitis B, reportedly cost MAD 5,266 ($526) in Morocco, while the identical medication from the same laboratory cost only MAD 580 ($58) in Turkey and approximately MAD 1,660 ($166) in France. The price difference shocked many Moroccans. The post's author claimed he had verified with Turkish sources that this was the normal market price in Turkey, not a subsidized rate, making the price in Morocco more than nine times higher. Unions have pointed out that dozens of medications in Morocco are sold at significantly higher prices than abroad, with some costing two to five times more than in Europe. Other industry sources suggested several possible explanations for the price discrepancies, including reference prices dropping in other countries while the medication was absent from the Moroccan market, successive devaluations of the Turkish lira, and differences in healthcare systems across reference countries. The controversy centers on Morocco's medication pricing system, which uses a decree more than ten years old. This system calculates prices based on rates in reference countries (France, Spain, Belgium, Portugal, Turkey, Saudi Arabia, and the country of origin), selecting the lowest price as reference. Fixed margins for distributors and pharmacists are then applied, plus a 7% VAT. Critics call this method rigid and disconnected from public health realities, as it fails to consider citizens' purchasing power, sales volume, or medical priorities. On July 21, Health Minister Amine Tahraoui announced to the House of Representatives that a new regulatory text is in its final phase and will soon be submitted to the Government Council. This reform aims to significantly reduce prices while balancing patient accessibility with support for local production. The minister detailed that this reform was developed through over 30 meetings with industry federations, pharmacist representatives, and insurance sector officials. The new model focuses on reducing price revision timeframes, implementing changes gradually to ensure market stability, protecting low-priced medications, and encouraging domestic production. Subsequent investigations, however, revealed that Baraclude hasn't been marketed in Morocco for at least five years. The medication was previously distributed by Maphar under license from Bristol-Myers Squibb before their local office closed. The AMMPS website confirms Baraclude's withdrawal from the market in both 0.5 mg and 1 mg versions. Several pharmacists confirmed that Opavir, the only generic alternative available in Morocco, has also been out of stock for several months, raising concerns about treatment options for chronic hepatitis B patients. Tags: medicationMedication prices in morocco
